Literature DB >> 17392653

Risk of hip fracture in Poland.

Maciej Jaworski1, Roman S Lorenc.   

Abstract

BACKGROUND: Bone fractures generate significant social costs, particularly in highly developed countries. This study was aimed at defining the number of hip fractures in Poland and evaluating absolute risk of fractures of this type within a period of 10 years and to the end of life. MATERIAL/
METHODS: Figures concerning hip fractures in the Mazowsze Province were provided by the Mazowsze Division of the National Health Fund. Data concerning male and female populations divided into age groups and with specified life expectancy were taken from the Central Bureau of Statistics. The number of hip fractures in Poland was estimated based on data for the Mazowsze Province. Lifetime and 10-year risks of hip fracture were calculated based on a model used by J. A. Kanis et al.
RESULTS: The estimated number of hip fractures in Poland was 27,434 (7970 in men, 19,464 in women). Lifetime risk of a hip fracture among men was 7.6% (40 years) to 1.6% (90 years) and from 13.6% to 2% among women, respectively. Ten-year risk of a hip fracture was maximal at the age of 80 and was 4.9% among men and 9.2% among women.
CONCLUSIONS: The study revealed a relatively large number hip fractures in Poland, amounting to approx. 30 thousand fractures per year. The expected increase in life expectancy in Poland, particularly among women, may result in significantly increased numbers of fractures in the nearest future and increased costs of their treatment.

Entities:  

Mesh:

Year:  2007        PMID: 17392653

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  7 in total

1.  Evaluation of FRAX to characterise fracture risk in Poland.

Authors:  E Czerwinski; J A Kanis; J Osieleniec; A Kumorek; A Milert; H Johansson; E V McCloskey; M Gorkiewicz
Journal:  Osteoporos Int       Date:  2010-12-03       Impact factor: 4.507

2.  The incidence and risk of hip fracture in Poland.

Authors:  E Czerwinski; J A Kanis; B Trybulec; H Johansson; P Borowy; J Osieleniec
Journal:  Osteoporos Int       Date:  2008-11-14       Impact factor: 4.507

Review 3.  A systematic review of hip fracture incidence and probability of fracture worldwide.

Authors:  J A Kanis; A Odén; E V McCloskey; H Johansson; D A Wahl; C Cooper
Journal:  Osteoporos Int       Date:  2012-03-15       Impact factor: 4.507

4.  Cognitive impairment and 1-year outcome in elderly patients with hip fracture.

Authors:  Yongzhi Guo; Tiansheng Sun; Xiaowei Wang; Shaoguang Li; Zhi Liu
Journal:  Med Sci Monit       Date:  2014-10-17

5.  Evaluation of the validity of treatment decisions based on surrogate country models before introduction of the Polish FRAX and recommendations in comparison to current practice.

Authors:  Wojciech M Glinkowski; Jerzy Narloch; Bożena Glinkowska; Małgorzata Bandura
Journal:  Arch Med Sci       Date:  2016-06-23       Impact factor: 3.318

6.  The role of counselling and other factors in compliance of postmenopausal osteoporotic patients to alendronate 70 therapy.

Authors:  Ewa Sewerynek; Hanna Horst-Sikorska; Wioletta Stępień-Kłos; Agnieszka Antkowiak; Małgorzata Janik; Karol Cieślak; Michalina Marcinkowska; Agnieszka Cegłowska; Michał Stuss
Journal:  Arch Med Sci       Date:  2013-04-22       Impact factor: 3.318

7.  The Increase of Osteoporotic Hip Fractures and Associated One-Year Mortality in Poland: 2008-2015.

Authors:  Wojciech Glinkowski; Jerzy Narloch; Krzysztof Krasuski; Andrzej Śliwczyński
Journal:  J Clin Med       Date:  2019-09-18       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.